Three Quantum Stocks Got the Same $100 Million. That's a Tie, Not a Ranking.

Same money, same day, same string attached. That is not a ranking.

On September 8, three pure-play quantum stocks each finalized a $100 million funding agreement with the U.S. Commerce Department: D-Wave, Rigetti, and the freshly public Quantinuum. The detail that should stop a retail reader is not the dollar figure. It is the form. In exchange for the money, the U.S. government takes a minority, non-controlling equity stake in each company. Washington is not printing research grants; it is buying a slice of the cap table, and the three are part of a roughly $2 billion, nine-company program Commerce outlined in May.

That single choice makes the headline question — "which of these is the best to buy now?" — structurally hard to answer, because all three received the identical prize at the identical moment on the identical terms. When every contestant starts with the same $100 million, the handout reveals nothing about how the race will go. It is the water they all swim in, not the difference between them.

So here is the card. All three trade on Nasdaq in dollars. All three get 100 paper points at the September 8 funding bell, and total return over the next twelve months is the official score, with no substitutions. The money itself is a tie, so a second scoreboard has to do the real work: the mechanism board, populated with numbers that were true before the check arrived — how much business each company already books, how long its cash lasts, and what multiple the market already charges.

The reaction was not a verdict. The news popped all three, then the pop faded; a couple of trading days later the shares were each down roughly 3%, which is what a gift that changes nothing does to a price.

The numbers that were true before the money arrived

Strip the $100 million away and the three are not a monolith. Their second-quarter revenue, in ascending order, is D-Wave at $3.1 million, Rigetti at $5.1 million, and Quantinuum at $8 million.

Now the growth question, because tiny revenue can still be growing or shrinking:

• Quantinuum grew fastest, up 279% year over year. It is also the heaviest spender by far: an adjusted EBITDA loss of $68 million in the quarter and a GAAP net loss of $597 million, on top of roughly $66 million a year of capital spending.
• Rigetti grew 185% year over year to $5.1 million, against an operating loss of $28.1 million, and reported $541.3 million in cash and investments.
• D-Wave reported topline revenue that fell year over year, yet its forward indicators exploded: first-half bookings of $35.5 million, up more than 1,120%, and remaining performance obligations — contracted revenue not yet delivered — of $40.7 million, up 668%.

Cash is the second bar, and here the check genuinely helps everyone. D-Wave reported about $588 million in cash this spring, up 93% year over year; Rigetti carries $541.3 million; Quantinuum, fresh off a $1.7 billion IPO, ended its quarter with $2.1 billion. The difference is what each company does with the runway. Quantinuum has the most cash and burns it fastest; Rigetti has a nine-figure cushion against a single-digit-million revenue base; D-Wave sits in between.

The valuation bar is where these stop looking like value plays at all. D-Wave trades around a $6.3 billion market cap on roughly $12 million of trailing revenue — on the order of 500 times sales. Quantinuum, at about $12.9 billion, carries a similar multiple. Both prices assume a decade of revenue that has not shown up yet.

Mechanically they are also betting on different physics: D-Wave builds both annealing and gate-model systems and aims at a 100,000-qubit annealing machine plus a 10,000-qubit gate system; Rigetti is chasing superconducting gate hardware and will spend its award on miniaturized readout electronics and cryostats; Quantinuum is the trapped-ion leader, touting near fault-tolerance on its Helios machine and an Oracle cloud partnership. The grant recipients are betting across the whole field, not concentrating on one horse.

Who clears the bar, and the bar that could move

The funding equalized the headline, not the company. Judged on booked business per dollar of market value, D-Wave's $40.7 million of contracted backlog against a $6 billion-plus cap is the most tangible commercial evidence on the board — but its cash-basis revenue actually fell, so whether that backlog converts into recognized revenue is precisely the variable to watch.

Quantinuum is the fastest grower and best financed, yet it demands the largest price for still-thin revenue and burns money at the fastest clip in the field. It is also the newest float: shares now trade below the $60 IPO price from June, a reminder that its recent momentum was priced in before the government check existed. Rigetti turned the strongest realized-growth-to-burn ratio of the three, though its market capitalization was the one figure that did not resolve cleanly in my data, so its relative multiple stays unfinished on this card.

The design lesson, in one line: three companies just received the same life raft, and now the government's minority stake means taxpayers share the upside you are paying a half-thousand-times-sales price for — which changes nothing about whether that revenue ever arrives. The $100 million was the tie, not the ranking.

Next checkpoint is the quarterly report cadence, and the two reversals to watch are D-Wave's backlog-to-revenue conversion and whether Quantinuum's 279% growth can outrun its quarterly losses. Do not mistake a headline handout for a differentiation: the scoreboard was set long before the check cleared.